Clinical phenotype and genetic analysis of a child with Hereditary hemorrhagic telangiectasia combined with growth hormone deficiency due to variant of ENG gene.
10.3760/cma.j.cn511374-20241204-00635
- Author:
Mengxin SUN
1
;
Hong YAN
;
Wenjie SUN
;
Jie WANG
;
Kunxia LI
Author Information
1. Department of Pediatrics, Yantai Yuhuangding Hospital, Yantai, Shandong 264001, China. ytyhdlkx@sina.com.
- Publication Type:English Abstract
- MeSH:
Humans;
Telangiectasia, Hereditary Hemorrhagic/complications*;
Male;
Child, Preschool;
Phenotype;
Endoglin/genetics*;
Mutation;
Human Growth Hormone/deficiency*;
Exome Sequencing
- From:
Chinese Journal of Medical Genetics
2025;42(11):1375-1380
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the clinical features and genetic etiology in a child with Hereditary hemorrhagic telangiectasia (HHT) complicated by growth hormone deficiency.
METHODS:A child presented at Yantai Yuhuangding Hospital in October 2014 for "short stature for over 4 years" was selected as the study subject. Peripheral venous blood samples were collected from the child and his parents for genomic DNA extraction and whole-exome sequencing (WES). The pathogenicity of the candidate variants was assessed by following the guidelines from the American College of Medical Genetics and Genomics (ACMG). This study was approved by the Medical Ethics Committee of the hospital (Ethics No.: 2025-003).
RESULTS:The patient, a 4-year-and-2-month-old male, presented with short stature and recurrent epistaxis since early childhood. Initial diagnosis of GHD was made via growth hormone stimulation testing. During follow-up, telangiectatic macules and polycythemia gradually appeared. WES revealed that he has harbored a heterozygous c.1807G>A (p.Gly603Arg) variant of the ENG gene, which was absent in both parents and classified as likely pathogenic based on ACMG guidelines. Sanger sequencing confirmed the candidate variant to be de novo.
CONCLUSION:Patients with HHT combined with GHD may exhibit clinical features such as short stature, telangiectasia, and arteriovenous malformations. The heterozygous c.1807G>A (p.Gly603Arg) variant of the ENG gene probably underlay the pathogenesis of the disease in the proband. Above finding has expanded the mutational spectrum of the ENG gene.
